Instructions for Submitting Papers
Manuscripts should be submitted electronically via SAGETRACK. Authors will be required to set up an online account on the SAGETRACK system powered by ScholarOne. After logging in, submissions are completed through your Author Center. Your title should be no more than 20 words, and your abstract no more than 180 words. Corresponding authors need to completely enter all co-author information as well. The manuscript to be uploaded should be completely devoid of any author identification, and be prepared using Microsoft Word. It should be ONE file starting with the abstract on page 1 and with the text starting on page 2. Following the text, arrange endnotes, references, appendices, tables, and figures, in this order. Manuscripts should generally follow the style guidelines of the American Medical Association (current edition). The Authorship Responsibility, Financial Disclosure, and Copyright Transfer Forms (these appear in every issue after the Information for Authors or are available on request from the Editorial Office at ict@blockmedical.com) should accompany all manuscripts. In addition, a letter describing the submission, the category to which it belongs, and its contribution to the medical literature is required. One author should be designated the corresponding author to receive galley proofs and reprint requests. The author’s complete mailing address, telephone and fax number, and email address should be included. Simultaneous submissions to other journals and previously published articles are not acceptable. Submission of a manuscript to Integrative Cancer Therapies implies commitment to publish in the journal.
Each manuscript must include the following:
1. Title page, including the full article title as well as an abbreviated form of the title for a running head; the name and academic degree(s) of each author, each author’s institutional affiliation, current mailing address, and business telephone and fax numbers; and the number of pages, illustrations, and tables in the manuscript.
2. An abstract of no more than 350 words. For research studies, please submit a structured abstract that summarizes the hypotheses, study design, methods, results, and conclusion. The abstract should be followed by 6 to 8 key words relating to the article.
3. Research articles should contain the following sections: Introduction (with brief literature review), Methods, Results, Discussion, and Conclusions, and may be up to 50 manuscript pages in length. Studies submitted should conscientiously adhere to ethical principles and practices, including informed consent in experiments involving human subjects, and humane practices in experiments on laboratory animals. Brief reports on preliminary research projects, of up to 10 pages, are also welcomed.
4. Review papers should include scholarly considerations and clinical implications, and may be up to 100 manuscript pages in length.
5. Case reports should explain the significance of the case, including relevant patient information, results of diagnostic tests, description of treatment and outcome, and may be up to 10 manuscript pages in length.
6. Educational articles provide shorter summaries of the state of research or practice in a facet of integrative cancer treatment. They may be up to 50 manuscript pages in length, should include a reference list, and should chiefly address the interests of practitioners.
7. Letters to the Editor of up to 1000 words in length will be considered. Those wishing to submit an Integrative Tumor Board or Point-Counterpoint should contact the editors.
Permissions. Submit with the manuscript written permissions to use nonoriginal materials (quotations of over 100 words in length, or any table or figure), from both the author and publisher of the original. Credit the source in the text or as a footnote in a figure legend. Any photographs of identifiable persons should be accompanied by signed releases that show informed consent.
References should be cited in the text using superscripted numbers, in numerical order; once a reference is cited, all subsequent citations of the same reference should use the original number (do not use ibid. or op. cit.). The journal uses the AMA reference style.
Figures submitted with manuscripts should be glossy prints or good-quality laser-printed illustrations. Photocopies are not acceptable. Copies of tables and illustrations, with labels and legends, should be of suitable quality to enable the referees to evaluate them. Electronic copies of figures must be submitted to the publisher; thus, we encourage the submission of figures electronically in the following formats: .tiff, .eps, .jpeg, and .prig. These may be submitted on diskette with the revised manuscript following acceptance. The figures should be numbered in the order in which they are discussed in the text. All figures should be mentioned in the text. The first author’s last name, the figure number, and an arrow to indicate the top edge of the figure should be on a label pasted on the back of each figure.
Tables should be numbered in the order in which they are mentioned in the text. Color figures or tables will be subject to a publication charge: please contact the editors about this. Tables should be used to present data and should have concise titles. Place each table on a separate page. Abbreviations should be introduced after the first occurrence of the term being abbreviated. Use standard metric units for measurements.
Please list sources of support such as grants. These may be included in an acknowledgments section placed after the discussion and conclusions.
For manuscripts not accepted for publication, one copy of the manuscript and glossy photographs will be returned to the corresponding author along with the reviewers’ comments.
Reprints. Authors will receive a schedule of reprint costs with galley proofs. Requests for reprints should be sent to Reprint Department, Sage Science Press, 2455 Teller Road, Thousand Oaks, CA 91320; or e-mail: reprint@sagepub.com
Publish Ahead of Print With Onlinefirst
Onlinefirst is a feature in which completed articles are published online prior to their inclusion in a print issue, offering authors the advantage of making their research accessible to the public in a more timely manner. Only online subscribers can view these PDFs, but abstracts are available to the public to view for free. Onlinefirst articles are fed to search engines and citation and content repositories, such as PubMed, MEDLINE, CrossRef, and Google Scholar, and therefore are available to be accessed and cited. Each Onlinefirst manuscript is citable by the publication date of the manuscript’s first online posting and the Digital Object Identifier (DOI), providing a persistent, permanent way to identify manuscripts published in the online environment. You can cite Onlinefirst articles as follows:
Author’s last name, first initials. Article title. Journal title. Prepublished month day, year; DOI: 10.1177/ 0123456789123456
Once your article has completed the production process and before it is published in a print issue, it will be posted online. You can access NNR Onlinefirst articles on the Web at http://nnr.sagepub.com/pap.dtl. Once posted online, articles may not be retracted or edited. If your article is not completed prior to its publication date, it will not go on Onlinefirst but will be posted online with the issue in which it is published.
Submit manuscripts to:
Keith I. Block, M.D.,
Editor-in-Chief, Integrative Cancer Therapies
Institute for Integrative Cancer Care
1800 Sherman Avenue, Suite 515
Evanston IL, 60201 USA
Telephone: 847-492-3040
E-mail: ict@blockmedical.com
For inquiries about the status of manuscripts after submission, please contact:
Charlotte Gyllenhaal, Ph.D.
Associate Editor, Integrative Cancer Therapies
Institute for Integrative Cancer Care
1800 Sherman Avenue, Suite 515
Evanston IL, 60201 USA
Telephone: 847-492-3040
E-mail: cgyllenhaal@blockmedical.com
To subscribe to Integrative Cancer Therapies, please visit http://www.sagepub.com or www.sagesciencepress.com and search under "Integrative Cancer Therapies."
Authors who want to refine the use of English in their manuscripts might consider utilizing the services of SPi, a non-affiliated company that offers Professional Editing Services to authors of journal articles in the areas of science, technology, medicine or the social sciences. SPi specializes in editing and correcting English-language manuscripts written by authors with a primary language other than English. Visit http://www.prof-editing.com for more information about SPi’s Professional Editing Services, pricing, and turn-around times, or to obtain a free quote or submit a manuscript for language polishing.
Please be aware that SAGE has no affiliation with SPi and makes no endorsement of the company. An author’s use of SPi’s services in no way guarantees that his or her submission will ultimately be accepted. Any arrangement an author enters into will be exclusively between the author and SPi, and any costs incurred are the sole responsibility of the author.
